{"id":59744,"date":"2026-06-10T03:04:51","date_gmt":"2026-06-10T03:04:51","guid":{"rendered":"https:\/\/www.europesays.com\/britain\/59744\/"},"modified":"2026-06-10T03:04:51","modified_gmt":"2026-06-10T03:04:51","slug":"market-open-bellway-demand-outlook-gsk-nuvalent-acquisition","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/britain\/59744\/","title":{"rendered":"Market Open: Bellway Demand Outlook, GSK Nuvalent Acquisition"},"content":{"rendered":"<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/06\/91923007648ca0cd75864ba7e98d7919.png\" alt=\"UK Market Open DOWN NEW SIZE\" loading=\"eager\" height=\"439\" width=\"800\" class=\"yf-lglytj  loaded\"\/> UK Market Open DOWN NEW SIZE      <\/p>\n<p class=\"yf-1fy9kyt\">FTSE 100 slips as investors monitor easing Middle East tensions. Bellway maintains guidance while GSK agrees an \u00a38bn cancer drug acquisition.<\/p>\n<p>      Market Overview    <\/p>\n<p class=\"yf-1fy9kyt\">European markets were mixed at the open as easing tensions in the Middle East helped stabilise investor sentiment. The FTSE 100 slipped 0.27 per cent to 10,325.57, while the CAC 40 fell 0.23 per cent and the DAX lost 0.58 per cent. In contrast, US markets finished higher overnight, with the Nasdaq gaining 0.65 per cent and the S&amp;P 500 adding 0.31 per cent. Investors continued to assess developments around Iran-Israel ceasefire efforts and the potential implications for energy markets and broader risk appetite.<\/p>\n<p class=\"yf-1fy9kyt\">Commodity markets reflected improving geopolitical sentiment. Brent crude moved lower after recent volatility linked to Middle East tensions, while copper and natural gas advanced. Gold was little changed as safe-haven demand eased. Sterling strengthened against the US dollar, euro, Japanese yen, Swiss franc and Australian dollar, while Bitcoin weakened against the pound. Markets remain focused on geopolitical developments, energy prices and the outlook for global economic growth.<\/p>\n<p>      Market Numbers    <\/p>\n<p class=\"yf-1fy9kyt\">FTSE 100: Down (-0.27%), 10,325.57<\/p>\n<p class=\"yf-1fy9kyt\">CAC40: Down (-0.23%), 8,199.290<\/p>\n<p class=\"yf-1fy9kyt\">DAX: Down (-0.58%), 24,616.22<\/p>\n<p class=\"yf-1fy9kyt\">NASDAQ: Up (0.65%), 29,573.0<\/p>\n<p class=\"yf-1fy9kyt\">S&amp;P 500: Up (0.31%), 7,425.0<\/p>\n<p>      In the Headlines    <\/p>\n<p class=\"yf-1fy9kyt\">Spring Demand Slows \u2013 Bellway (LSE:BWY)<\/p>\n<p class=\"yf-1fy9kyt\">Bellway said higher mortgage costs softened demand during the spring selling season, although reservation rates and cancellation levels remained broadly stable. The housebuilder maintained its full-year profit and completion guidance, signalling confidence in underlying market conditions despite affordability pressures.<\/p>\n<p class=\"yf-1fy9kyt\">Cancer Drug Acquisition \u2013 GSK (LSE:GSK)<\/p>\n<p class=\"yf-1fy9kyt\">GSK has agreed to acquire US lung cancer specialist Nuvalent in a deal worth approximately \u00a38 billion. The transaction strengthens GSK\u2019s oncology pipeline and underlines the company\u2019s strategy of expanding its portfolio of targeted cancer treatments.<\/p>\n<p>      Currencies (vs GBP)    <\/p>\n<p class=\"yf-1fy9kyt\">USD: Up (0.20%), $1.3365<\/p>\n<p class=\"yf-1fy9kyt\">CHF: Up (0.09%), Fr.1.06506<\/p>\n<p class=\"yf-1fy9kyt\">EUR: Up (0.15%), \u20ac1.1578<\/p>\n<p class=\"yf-1fy9kyt\">JPY: Up (0.20%), \u00a5214.076<\/p>\n<p class=\"yf-1fy9kyt\">AUD: Up (0.13%), $1.894520<\/p>\n<p class=\"yf-1fy9kyt\">Bitcoin (BTC\/GBP): Down (-0.37%), \u00a347,144.1<\/p>\n<p>      Commodities    <\/p>\n<p class=\"yf-1fy9kyt\">Copper: Up (0.78%), 6.42364<\/p>\n<p class=\"yf-1fy9kyt\">Gold: Up (0.01%), 4,330.29<\/p>\n<p class=\"yf-1fy9kyt\">Brent Crude: Down (-1.30%), 92.202<\/p>\n<p class=\"yf-1fy9kyt\">Natural Gas: Up (0.63%), 3.173<\/p>\n","protected":false},"excerpt":{"rendered":"UK Market Open DOWN NEW SIZE FTSE 100 slips as investors monitor easing Middle East tensions. Bellway maintains&hellip;\n","protected":false},"author":2,"featured_media":59745,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[20784],"tags":[24254,22505,320,20785,25517,13373,42],"class_list":["post-59744","post","type-post","status-publish","format-standard","has-post-thumbnail","category-gsk","tag-bellway","tag-commodity-markets","tag-ftse-100","tag-gsk","tag-investor-sentiment","tag-market-overview","tag-middle-east"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@UnitedKingdom\/116723602170450556","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/59744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=59744"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/59744\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/59745"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=59744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=59744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=59744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}